Hjem
Universitetet i Bergen
Heidi Syres bilde

Heidi Syre

Gjesteforsker
Klinisk institutt 2
  • E-postH.Syre@uib.no
  • Besøksadresse
    Haukeland universitetssykehus, Laboratoriebygget
    5009 Bergen
  • Postadresse
    Postboks 7804
    5020 Bergen
Vitenskapelig artikkel
  • Vis forfatter(e) (2023). Risk assessment and antibody responses to SARS-CoV-2 in healthcare workers. Frontiers in Public Health. 13 sider.
  • Vis forfatter(e) (2023). Attitudes and self-efficacy towards infection prevention and control and antibiotic stewardship among nurses : a mixed-methods study. Journal of Clinical Nursing (JCN). 6268-6286.
  • Vis forfatter(e) (2023). An Epidemiological Study of Aeromonas spp. Infections in Norway. Austin Journal of Public Health and Epidemiology. 1-7.
  • Vis forfatter(e) (2022). The performances of three commercially available assays for the detection of SARS‐CoV‐2 antibodies at different time points following SARS‐CoV‐2 infection. Viruses. 1-11.
  • Vis forfatter(e) (2021). Neuroborreliosis with severe mental confusion and thickening of cranial nerves. IDCases.
  • Vis forfatter(e) (2021). En mann i 80-årene med gangvansker og høy CRP-verdi. Tidsskrift for Den norske legeforening.
  • Vis forfatter(e) (2020). Xpert MTB/RIF Ultra for rapid diagnosis of extrapulmonary tuberculosis in a high-income low-tuberculosis prevalence setting. Scientific Reports.
  • Vis forfatter(e) (2020). Twenty years of endophthalmitis: Incidence, aetiology and clinical outcome. Acta Ophthalmologica. 1-8.
  • Vis forfatter(e) (2020). Diagnosis of extrapulmonary tuberculosis using the MPT64 antigen detection test in a high-income low tuberculosis prevalence setting. BMC Infectious Diseases. 1-11.
  • Vis forfatter(e) (2019). Use of microbiology tests in the era of increasing AMR rates- a multicentre hospital cohort study. Antimicrobial Resistance and Infection Control. 1-8.
  • Vis forfatter(e) (2019). Microbial risk factors for treatment failure of pivmecillinam in community‐acquired urinary tract infections caused by ESBL‐producing Escherichia coli. APMIS - Journal of Pathologiy, Microbiology and Immunology. 1-10.
  • Vis forfatter(e) (2018). Stratification by interferon-γ release assay level predicts risk of incident TB. Thorax. 652-661.
  • Vis forfatter(e) (2014). Portal cytokine response and metabolic markers in the early stages of abdominal sepsis in pigs. European Surgical Research. 21-31.
  • Vis forfatter(e) (2010). Determination of the susceptibility of Mycobacterium tuberculosis to pyrazinamide in liquid and solid media assessed by a colorimetric nitrate reductase assay. Journal of Antimicrobial Chemotherapy. 704-712.
  • Vis forfatter(e) (2009). Isoniazid and rifampicin resistance-asTisociated mutations in Mycobacterium tuberculosis isolates from Yangon, Myanmar: implications for rapid molecular testing. Journal of Antimicrobial Chemotherapy. 694-701.
  • Vis forfatter(e) (2009). Direct detection of mycobacterial species in pulmonary specimens by two rapid amplification tests, the gen-probe amplified mycobacterium tuberculosis direct test and the genotype mycobacteria direct test. Journal of Clinical Microbiology. 3635-3639.
  • Vis forfatter(e) (2006). Evaluation of the nitrate-based colorimetric method for testing the susceptibility of Mycobacterium tuberculosis to streptomycin and ethambutol in liquid cultures. Journal of Antimicrobial Chemotherapy. 987-991.
Rapport
  • Vis forfatter(e) (2017). Mykobakteriediagnostikk. Strategimøte nr. 30, 2016. 2016:30. 2016:30. .
Doktorgradsavhandling
  • Vis forfatter(e) (2010). Antibiotic susceptibility testing of Mycobacterium tuberculosis.
Vitenskapelig Kapittel/Artikkel/Konferanseartikkel
  • Vis forfatter(e) (2011). Immunology of Tubercolosis: Basic Aspects and Relevance for Immunodiagnostic Tests. 24 sider.
Poster
  • Vis forfatter(e) (2007). Testing pyrazinamide resistance among South African multidrug-resistant Mycobacterium tuberculosis isolates.

Se fullstendig oversikt over publikasjoner i CRIStin.